Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocol.
Collaborative care
Cost-effectiveness
Cost-utility
Depression
Elderly
Emotional distress
Health economic evaluation
Heart failure
Multimorbidity
Time-driven activity-based costing
Journal
Cost effectiveness and resource allocation : C/E
ISSN: 1478-7547
Titre abrégé: Cost Eff Resour Alloc
Pays: England
ID NLM: 101170476
Informations de publication
Date de publication:
13 Apr 2024
13 Apr 2024
Historique:
received:
10
11
2023
accepted:
21
03
2024
medline:
14
4
2024
pubmed:
14
4
2024
entrez:
13
4
2024
Statut:
epublish
Résumé
Integrated care, in particular the 'Blended Collaborative Care (BCC)' strategy, may have the potential to improve health-related quality of life (HRQoL) in multimorbid patients with heart failure (HF) and psychosocial burden at no or low additional cost. The ESCAPE trial is a randomised controlled trial for the evaluation of a BCC approach in five European countries. For the economic evaluation of alongside this trial, the four main objectives were: (i) to document the costs of delivering the intervention, (ii) to assess the running costs across study sites, (iii) to evaluate short-term cost-effectiveness and cost-utility compared to providers' usual care, and (iv) to examine the budgetary implications. The trial-based economic analyses will include cross-country cost-effectiveness and cost-utility assessments from a payer perspective. The cost-utility analysis will calculate quality-adjusted life years (QALYs) using the EQ-5D-5L and national value sets. Cost-effectiveness will include the cost per hospital admission avoided and the cost per depression-free days (DFD). Resource use will be measured from different sources, including electronic medical health records, standardised questionnaires, patient receipts and a care manager survey. Uncertainty will be addressed using bootstrapping. The various methods and approaches used for data acquisition should provide insights into the potential benefits and cost-effectiveness of a BCC intervention. Providing the economic evaluation of ESCAPE will contribute to a country-based structural and organisational planning of BCC (e.g., the number of patients that may benefit, how many care managers are needed). Improved care is expected to enhance health-related quality of life at little or no extra cost. The study follows CHEERS2022 and is registered at the German Clinical Trials Register (DRKS00025120).
Sections du résumé
BACKGROUND
BACKGROUND
Integrated care, in particular the 'Blended Collaborative Care (BCC)' strategy, may have the potential to improve health-related quality of life (HRQoL) in multimorbid patients with heart failure (HF) and psychosocial burden at no or low additional cost. The ESCAPE trial is a randomised controlled trial for the evaluation of a BCC approach in five European countries. For the economic evaluation of alongside this trial, the four main objectives were: (i) to document the costs of delivering the intervention, (ii) to assess the running costs across study sites, (iii) to evaluate short-term cost-effectiveness and cost-utility compared to providers' usual care, and (iv) to examine the budgetary implications.
METHODS
METHODS
The trial-based economic analyses will include cross-country cost-effectiveness and cost-utility assessments from a payer perspective. The cost-utility analysis will calculate quality-adjusted life years (QALYs) using the EQ-5D-5L and national value sets. Cost-effectiveness will include the cost per hospital admission avoided and the cost per depression-free days (DFD). Resource use will be measured from different sources, including electronic medical health records, standardised questionnaires, patient receipts and a care manager survey. Uncertainty will be addressed using bootstrapping.
DISCUSSION
CONCLUSIONS
The various methods and approaches used for data acquisition should provide insights into the potential benefits and cost-effectiveness of a BCC intervention. Providing the economic evaluation of ESCAPE will contribute to a country-based structural and organisational planning of BCC (e.g., the number of patients that may benefit, how many care managers are needed). Improved care is expected to enhance health-related quality of life at little or no extra cost.
TRIAL REGISTRATION
BACKGROUND
The study follows CHEERS2022 and is registered at the German Clinical Trials Register (DRKS00025120).
Identifiants
pubmed: 38615050
doi: 10.1186/s12962-024-00535-2
pii: 10.1186/s12962-024-00535-2
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29Informations de copyright
© 2024. The Author(s).
Références
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272–87. https://doi.org/10.1093/cvr/cvac013 .
doi: 10.1093/cvr/cvac013
pubmed: 35150240
Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1:4–25. https://doi.org/10.1002/ehf2.12005 .
doi: 10.1002/ehf2.12005
pubmed: 28834669
Forman DE, Maurer MS, Boyd C, Brindis R, Salive ME, Horne FM, et al. Multimorbidity in older adults with Cardiovascular Disease. J Am Coll Cardiol. 2018;71:2149–61. https://doi.org/10.1016/j.jacc.2018.03.022 .
doi: 10.1016/j.jacc.2018.03.022
pubmed: 29747836
pmcid: 6028235
Muntingh AD, van der Feltz-Cornelis CM, van Marwijk HW, Spinhoven P, van Balkom AJ. Collaborative care for anxiety disorders in primary care: a systematic review and meta-analysis. BMC Fam Pract. 2016;17:62. https://doi.org/10.1186/s12875-016-0466-3 .
doi: 10.1186/s12875-016-0466-3
pubmed: 27250527
pmcid: 4890271
Tully PJ, Baumeister H. Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2015;5:e009128. https://doi.org/10.1136/bmjopen-2015-009128 .
doi: 10.1136/bmjopen-2015-009128
pubmed: 26692557
pmcid: 4691772
Rollman BL, Anderson AM, Rothenberger SD, Abebe KZ, Ramani R, Muldoon MF, et al. Efficacy of blended collaborative care for patients with heart failure and Comorbid Depression: a Randomized Clinical Trial. JAMA Intern Med. 2021;181:1369–80. https://doi.org/10.1001/jamainternmed.2021.4978 .
doi: 10.1001/jamainternmed.2021.4978
pubmed: 34459842
pmcid: 8406216
Katon W, Russo J, Lin EH, Schmittdiel J, Ciechanowski P, Ludman E, et al. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry. 2012;69:506–14. https://doi.org/10.1001/archgenpsychiatry.2011.1548 .
doi: 10.1001/archgenpsychiatry.2011.1548
pubmed: 22566583
Grochtdreis T, Brettschneider C, Wegener A, Watzke B, Riedel-Heller S, Härter M, et al. Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review. PLoS ONE. 2015;10:e0123078. https://doi.org/10.1371/journal.pone.0123078 .
doi: 10.1371/journal.pone.0123078
pubmed: 25993034
pmcid: 4437997
Hildebrandt H, Pimperl A, Schulte T, Hermann C, Riedel H, Schubert I, et al. Triple Aim - Evaluation in Der Integrierten Versorgung Gesundes Kinzigtal - Gesundheitszustand, Versorgungserleben Und Wirtschaftlichkeit. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58:383–92. https://doi.org/10.1007/s00103-015-2120-y .
doi: 10.1007/s00103-015-2120-y
pubmed: 25652116
Hildebrandt H, Schulte T, Stunder B. Triple Aim in Kinzigtal, Germany. J Integr Care. 2012;20:205–22. https://doi.org/10.1108/14769011211255249 .
doi: 10.1108/14769011211255249
Donohue JM, Belnap BH, Men A, He F, Roberts MS, Schulberg HC, et al. Twelve-month cost-effectiveness of telephone-delivered collaborative care for treating depression following CABG surgery: a randomized controlled trial. Gen Hosp Psychiatry. 2014;36:453–9. https://doi.org/10.1016/j.genhosppsych.2014.05.012 .
doi: 10.1016/j.genhosppsych.2014.05.012
pubmed: 24973911
pmcid: 4138244
Sahlen K-G, Boman K, Brännström M. A cost-effectiveness study of person-centered integrated heart failure and palliative home care: based on a randomized controlled trial. Palliat Med. 2016;30:296–302. https://doi.org/10.1177/0269216315618544 .
doi: 10.1177/0269216315618544
pubmed: 26603186
Hujala A, Rijken M, Oksman E, Taskinen H, Rissanen S. The POTKU project (Potilas kuljettajan paikalle, Putting the Patient in the Driver’s Seat). Finland.
Katon WJ, Lin EH, von Korff M, Ciechanowski P, Ludman EJ, Young B, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363:2611–20. https://doi.org/10.1056/NEJMoa1003955 .
doi: 10.1056/NEJMoa1003955
pubmed: 21190455
pmcid: 3312811
Zelenak C, Nagel J, Bersch K, Derendorf L, Doyle F, Friede T, et al. Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study. ESC Heart Fail. 2023;10:2051–65. https://doi.org/10.1002/ehf2.14294 .
doi: 10.1002/ehf2.14294
pubmed: 36907651
pmcid: 10192276
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: United Kingdom); 2015. XIII, 445 str.
Turner HC, Archer RA, Downey LE, Isaranuwatchai W, Chalkidou K, Jit M, et al. An introduction to the Main types of economic evaluations used for Informing Priority setting and Resource Allocation in Healthcare: key features, uses, and limitations. Front Public Health. 2021;9:722927. https://doi.org/10.3389/fpubh.2021.722927 .
doi: 10.3389/fpubh.2021.722927
pubmed: 34513790
pmcid: 8424074
Matter-Walstra K, Klingbiel D, Szucs T, Pestalozzi BC, Schwenkglenks M. Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied? PharmacoEconomics. 2014;32:591–9. https://doi.org/10.1007/s40273-014-0151-0 .
doi: 10.1007/s40273-014-0151-0
pubmed: 24671924
Lave JR, Frank RG, Schulberg HC, Kamlet MS. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry. 1998;55:645–51. https://doi.org/10.1001/archpsyc.55.7.645 .
doi: 10.1001/archpsyc.55.7.645
pubmed: 9672056
Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22:1717–27. https://doi.org/10.1007/s11136-012-0322-4 .
doi: 10.1007/s11136-012-0322-4
pubmed: 23184421
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36. https://doi.org/10.1007/s11136-011-9903-x .
doi: 10.1007/s11136-011-9903-x
pubmed: 21479777
pmcid: 3220807
McMahon SE, Diamond OJ, Cusick LA. Coned hemipelvis reconstruction for osteoporotic acetabular fractures in frail elderly patients. Bone Joint J. 2020;102–B:155–61. https://doi.org/10.1302/0301-620X.102B2.BJJ-2019-0883.R2 .
doi: 10.1302/0301-620X.102B2.BJJ-2019-0883.R2
pubmed: 32009440
Mercer SW, Fitzpatrick B, Guthrie B, Fenwick E, Grieve E, Lawson K, et al. The CARE Plus study - a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysis. BMC Med. 2016;14:88. https://doi.org/10.1186/s12916-016-0634-2 .
doi: 10.1186/s12916-016-0634-2
pubmed: 27328975
pmcid: 4916534
Spertus JA, Jones PG. Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes. 2015;8:469–76. https://doi.org/10.1161/CIRCOUTCOMES.115.001958 .
doi: 10.1161/CIRCOUTCOMES.115.001958
pubmed: 26307129
pmcid: 4885562
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x .
doi: 10.1111/j.1600-0447.1983.tb09716.x
pubmed: 6880820
Da Etges AP, Polanczyk CA, Urman RD. A standardized framework to evaluate the quality of studies using TDABC in healthcare: the TDABC in Healthcare Consortium Consensus Statement. BMC Health Serv Res. 2020;20:1107. https://doi.org/10.1186/s12913-020-05869-0 .
doi: 10.1186/s12913-020-05869-0
pubmed: 33256733
pmcid: 7706254
Keel G, Savage C, Rafiq M, Mazzocato P. Time-driven activity-based costing in health care: a systematic review of the literature. Health Policy. 2017;121:755–63. https://doi.org/10.1016/j.healthpol.2017.04.013 .
doi: 10.1016/j.healthpol.2017.04.013
pubmed: 28535996
El Alaoui S, Lindefors N. Combining Time-Driven activity-based costing with clinical outcome in cost-effectiveness analysis to measure value in treatment of Depression. PLoS ONE. 2016;11:e0165389. https://doi.org/10.1371/journal.pone.0165389 .
doi: 10.1371/journal.pone.0165389
pubmed: 27798655
pmcid: 5087942
Simões Corrêa Galendi J, Yeo SY, Simic D, Grüll H, Stock S, Müller D. A time-driven activity-based costing approach of magnetic resonance-guided high-intensity focused ultrasound for cancer-induced bone pain. Int J Hyperth. 2022;39:173–80. https://doi.org/10.1080/02656736.2021.2023768 .
doi: 10.1080/02656736.2021.2023768
Yu YR, Abbas PI, Smith CM, Carberry KE, Ren H, Patel B, et al. Time-driven activity-based costing: a dynamic value assessment model in pediatric appendicitis. J Pediatr Surg. 2017;52:1045–9. https://doi.org/10.1016/j.jpedsurg.2017.03.032 .
doi: 10.1016/j.jpedsurg.2017.03.032
pubmed: 28363470
iMTA Productivity and Health Research Group. Manual iMTA Medical Cost Questionnaire (iMCQ). Rotterdam. (2018) [cited 2023 Sep 04]. Available from: https://www.imta.nl/questionnaires/imcq/ .
Olaison A, Torres S, Forssell E. Professional discretion and length of work experience: what findings from focus groups with care managers in elder care suggest. J Social Work Pract. 2018;32:153–67. https://doi.org/10.1080/02650533.2018.1438995 .
doi: 10.1080/02650533.2018.1438995
Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005;8:521–33. https://doi.org/10.1111/j.1524-4733.2005.00045.x .
doi: 10.1111/j.1524-4733.2005.00045.x
pubmed: 16176491
Briggs AH, O’Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health. 2002;23:377–401. https://doi.org/10.1146/annurev.publhealth.23.100901.140534 .
doi: 10.1146/annurev.publhealth.23.100901.140534
pubmed: 11910068
Fenwick E, O’Brien BJ, Briggs A. Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ. 2004;13:405–15. https://doi.org/10.1002/hec.903 .
doi: 10.1002/hec.903
pubmed: 15127421
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 2022;20:23. https://doi.org/10.1186/s12916-021-02204-0 .
doi: 10.1186/s12916-021-02204-0
pubmed: 35022047
pmcid: 8753858
Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation. 2004;110:546–51. https://doi.org/10.1161/01.CIR.0000136991.85540.A9 .
doi: 10.1161/01.CIR.0000136991.85540.A9
pubmed: 15262843
Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:2379–90. https://doi.org/10.1016/j.jacc.2020.09.542 .
doi: 10.1016/j.jacc.2020.09.542
pubmed: 33183512
Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, et al. Accuracy of the hospital anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021;373:n972. https://doi.org/10.1136/bmj.n972 .
doi: 10.1136/bmj.n972
pubmed: 33972268
pmcid: 8107836
Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, van Hemert AM. A validation study of the hospital anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27:363–70. https://doi.org/10.1017/s0033291796004382 .
doi: 10.1017/s0033291796004382
pubmed: 9089829
Choi Yoo SJ, Nyman JA, Cheville AL, Kroenke K. Cost effectiveness of telecare management for pain and depression in patients with cancer: results from a randomized trial. Gen Hosp Psychiatry. 2014;36:599–606. https://doi.org/10.1016/j.genhosppsych.2014.07.004 .
doi: 10.1016/j.genhosppsych.2014.07.004
pubmed: 25130518
pmcid: 4252770
Simon GE, VonKorff M, Heiligenstein JH, Revicki DA, Grothaus L, Katon W, et al. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA. 1996;275:1897–902.
doi: 10.1001/jama.1996.03530480039038
pubmed: 8648870
Pyne JM, Tripathi S, Williams DK, Fortney J. Depression-free day to utility-weighted score: is it valid? Med Care. 2007;45:357–62. https://doi.org/10.1097/01.mlr.0000256971.81184.aa .
doi: 10.1097/01.mlr.0000256971.81184.aa
pubmed: 17496720
Schoenbaum M, Unützer J, Sherbourne C, Duan N, Rubenstein LV, Miranda J, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA. 2001;286:1325–30. https://doi.org/10.1001/jama.286.11.1325 .
doi: 10.1001/jama.286.11.1325
pubmed: 11560537
Revicki DA, Wood M. Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J Affect Disord. 1998;48:25–36. https://doi.org/10.1016/S0165-0327(97)00117-1 .
doi: 10.1016/S0165-0327(97)00117-1
pubmed: 9495599